These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 28367235)
41. A genetic model to dissect the role of Tsc-mTORC1 in neuronal cultures. Nie D; Sahin M Methods Mol Biol; 2012; 821():393-405. PubMed ID: 22125080 [TBL] [Abstract][Full Text] [Related]
42. Biallelic Mutations in Winden KD; Sundberg M; Yang C; Wafa SMA; Dwyer S; Chen PF; Buttermore ED; Sahin M J Neurosci; 2019 Nov; 39(47):9294-9305. PubMed ID: 31591157 [TBL] [Abstract][Full Text] [Related]
43. Regionally specific TSC1 and TSC2 gene expression in tuberous sclerosis complex. Li Y; Barkovich MJ; Karch CM; Nillo RM; Fan CC; Broce IJ; Tan CH; Cuneo D; Hess CP; Dillon WP; Glenn OA; Glastonbury CM; Olney N; Yokoyama JS; Bonham LW; Miller B; Kao A; Schmansky N; Fischl B; Andreassen OA; Jernigan T; Dale A; Barkovich AJ; Desikan RS; Sugrue LP Sci Rep; 2018 Sep; 8(1):13373. PubMed ID: 30190613 [TBL] [Abstract][Full Text] [Related]
45. Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation. Hwang SK; Lee JH; Yang JE; Lim CS; Lee JA; Lee YS; Lee K; Kaang BK Mol Brain; 2016 May; 9(1):56. PubMed ID: 27216612 [TBL] [Abstract][Full Text] [Related]
46. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Jones AC; Shyamsundar MM; Thomas MW; Maynard J; Idziaszczyk S; Tomkins S; Sampson JR; Cheadle JP Am J Hum Genet; 1999 May; 64(5):1305-15. PubMed ID: 10205261 [TBL] [Abstract][Full Text] [Related]
47. Therapeutic targeting of mTOR in tuberous sclerosis. Sampson JR Biochem Soc Trans; 2009 Feb; 37(Pt 1):259-64. PubMed ID: 19143643 [TBL] [Abstract][Full Text] [Related]
48. Ho DWH; Chan LK; Chiu YT; Xu IMJ; Poon RTP; Cheung TT; Tang CN; Tang VWL; Lo ILO; Lam PWY; Yau DTW; Li MX; Wong CM; Ng IOL Gut; 2017 Aug; 66(8):1496-1506. PubMed ID: 27974549 [TBL] [Abstract][Full Text] [Related]
49. Not all kidney cysts are created equal: a distinct renal cystogenic mechanism in tuberous sclerosis complex (TSC). Soleimani M Front Physiol; 2023; 14():1289388. PubMed ID: 38028758 [TBL] [Abstract][Full Text] [Related]
51. A novel mouse model of tuberous sclerosis complex (TSC): eye-specific Tsc1-ablation disrupts visual-pathway development. Jones I; Hägglund AC; Törnqvist G; Nord C; Ahlgren U; Carlsson L Dis Model Mech; 2015 Dec; 8(12):1517-29. PubMed ID: 26449264 [TBL] [Abstract][Full Text] [Related]
52. Case Report: Tuberous sclerosis complex-associated hemihypertrophy successfully treated with mTOR inhibitor sirolimus. Shimoda K; Iwasaki H; Mizuno Y; Seki M; Mimaki M; Kato M; Shinozaki-Ushiku A; Mori H; Ogawa S; Mizuguchi M Front Pediatr; 2024; 12():1333064. PubMed ID: 38455392 [TBL] [Abstract][Full Text] [Related]
53. Pivotal role of augmented αB-crystallin in tumor development induced by deficient TSC1/2 complex. Wang F; Chen X; Li C; Sun Q; Chen Y; Wang Y; Peng H; Liu Z; Chen R; Liu K; Yan H; Ye BH; Kwiatkowski DJ; Zhang H Oncogene; 2014 Aug; 33(34):4352-8. PubMed ID: 24077282 [TBL] [Abstract][Full Text] [Related]
54. The dual PI3K/mTOR inhibitor GSK2126458 is effective for treating solid renal tumours in Narov K; Yang J; Samsel P; Jones A; Sampson JR; Shen MH Oncotarget; 2017 Aug; 8(35):58504-58512. PubMed ID: 28938574 [TBL] [Abstract][Full Text] [Related]
55. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Jones AC; Daniells CE; Snell RG; Tachataki M; Idziaszczyk SA; Krawczak M; Sampson JR; Cheadle JP Hum Mol Genet; 1997 Nov; 6(12):2155-61. PubMed ID: 9328481 [TBL] [Abstract][Full Text] [Related]
56. Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex. Hoogeveen-Westerveld M; Ekong R; Povey S; Karbassi I; Batish SD; den Dunnen JT; van Eeghen A; Thiele E; Mayer K; Dies K; Wen L; Thompson C; Sparagana SP; Davies P; Aalfs C; van den Ouweland A; Halley D; Nellist M Hum Mutat; 2012 Mar; 33(3):476-9. PubMed ID: 22161988 [TBL] [Abstract][Full Text] [Related]